Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 14 | 2023 | 775 | 3.810 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2023 | 226 | 2.230 |
Why?
|
| Influenza Vaccines | 4 | 2019 | 56 | 1.970 |
Why?
|
| Bacterial Translocation | 5 | 2019 | 27 | 1.170 |
Why?
|
| Lymphocyte Activation | 3 | 2019 | 397 | 1.150 |
Why?
|
| Influenza, Human | 4 | 2019 | 79 | 1.070 |
Why?
|
| Autoantibodies | 5 | 2023 | 434 | 0.960 |
Why?
|
| CD4 Lymphocyte Count | 7 | 2023 | 98 | 0.940 |
Why?
|
| Immunoglobulin G | 5 | 2023 | 481 | 0.920 |
Why?
|
| Antiretroviral Therapy, Highly Active | 5 | 2022 | 73 | 0.910 |
Why?
|
| Antibodies, Viral | 3 | 2019 | 110 | 0.910 |
Why?
|
| Anti-Retroviral Agents | 3 | 2019 | 53 | 0.870 |
Why?
|
| Immune Reconstitution | 1 | 2022 | 4 | 0.860 |
Why?
|
| Saliva | 1 | 2021 | 142 | 0.770 |
Why?
|
| Bacteria | 2 | 2021 | 193 | 0.770 |
Why?
|
| Marijuana Smoking | 1 | 2021 | 108 | 0.750 |
Why?
|
| Lipopolysaccharides | 5 | 2022 | 455 | 0.740 |
Why?
|
| Amyloid beta-Peptides | 1 | 2021 | 190 | 0.740 |
Why?
|
| Killer Cells, Natural | 2 | 2017 | 94 | 0.720 |
Why?
|
| B-Lymphocytes | 4 | 2016 | 329 | 0.720 |
Why?
|
| HIV-1 | 4 | 2021 | 177 | 0.710 |
Why?
|
| Antibody Affinity | 1 | 2019 | 26 | 0.690 |
Why?
|
| Staphylococcus | 1 | 2019 | 29 | 0.680 |
Why?
|
| Macrophages | 1 | 2021 | 647 | 0.630 |
Why?
|
| Apoptosis | 4 | 2017 | 1640 | 0.560 |
Why?
|
| Brain | 1 | 2021 | 2175 | 0.390 |
Why?
|
| DNA, Ribosomal | 2 | 2021 | 59 | 0.370 |
Why?
|
| CD4 Antigens | 2 | 2022 | 42 | 0.370 |
Why?
|
| DNA, Bacterial | 2 | 2021 | 150 | 0.360 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2021 | 85 | 0.340 |
Why?
|
| Case-Control Studies | 4 | 2021 | 1548 | 0.320 |
Why?
|
| Humans | 19 | 2023 | 68525 | 0.310 |
Why?
|
| Cell Line | 2 | 2022 | 1752 | 0.310 |
Why?
|
| Mice | 5 | 2022 | 8472 | 0.300 |
Why?
|
| Antibodies, Neutralizing | 2 | 2016 | 46 | 0.280 |
Why?
|
| Sex Factors | 3 | 2019 | 1265 | 0.270 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2022 | 756 | 0.250 |
Why?
|
| Female | 12 | 2022 | 38015 | 0.240 |
Why?
|
| Inflammation | 2 | 2021 | 1030 | 0.220 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2550 | 0.220 |
Why?
|
| Antibodies, Antinuclear | 2 | 2022 | 171 | 0.220 |
Why?
|
| Middle Aged | 8 | 2022 | 21119 | 0.220 |
Why?
|
| Lipid A | 1 | 2022 | 9 | 0.220 |
Why?
|
| Adult | 8 | 2022 | 21375 | 0.220 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2022 | 4 | 0.210 |
Why?
|
| Male | 10 | 2022 | 37281 | 0.210 |
Why?
|
| Animals | 5 | 2022 | 20877 | 0.200 |
Why?
|
| Autoantigens | 1 | 2022 | 91 | 0.200 |
Why?
|
| Cyclic AMP | 1 | 2022 | 223 | 0.200 |
Why?
|
| Staphylococcus aureus | 1 | 2022 | 175 | 0.200 |
Why?
|
| Protein Isoforms | 1 | 2022 | 246 | 0.200 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 208 | 0.200 |
Why?
|
| Immunologic Memory | 3 | 2016 | 75 | 0.190 |
Why?
|
| Phylogeny | 1 | 2021 | 196 | 0.190 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 99 | 0.190 |
Why?
|
| Graft vs Host Disease | 1 | 2022 | 163 | 0.180 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 245 | 0.180 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 2 | 2016 | 13 | 0.180 |
Why?
|
| Germinal Center | 1 | 2019 | 13 | 0.170 |
Why?
|
| Anti-HIV Agents | 2 | 2018 | 135 | 0.170 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 68 | 0.170 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 35 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 2790 | 0.170 |
Why?
|
| Microbiota | 1 | 2019 | 79 | 0.160 |
Why?
|
| Immunity, Innate | 1 | 2019 | 156 | 0.160 |
Why?
|
| Membrane Cofactor Protein | 1 | 2017 | 7 | 0.160 |
Why?
|
| HIV Antibodies | 1 | 2018 | 28 | 0.160 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 66 | 0.160 |
Why?
|
| Estrogen Receptor beta | 1 | 2017 | 19 | 0.160 |
Why?
|
| Pregnancy Trimester, First | 1 | 2017 | 43 | 0.160 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2017 | 25 | 0.160 |
Why?
|
| Transcription Factors | 1 | 2022 | 753 | 0.150 |
Why?
|
| Family | 1 | 2019 | 293 | 0.150 |
Why?
|
| Chemokine CCL2 | 1 | 2017 | 101 | 0.150 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2017 | 8 | 0.150 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2017 | 7 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2022 | 447 | 0.150 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2017 | 24 | 0.150 |
Why?
|
| Estrogen Receptor alpha | 1 | 2017 | 65 | 0.150 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 1293 | 0.140 |
Why?
|
| Estradiol | 1 | 2017 | 176 | 0.140 |
Why?
|
| Up-Regulation | 1 | 2019 | 682 | 0.140 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2015 | 5 | 0.140 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2015 | 10 | 0.140 |
Why?
|
| Neutralization Tests | 1 | 2015 | 19 | 0.140 |
Why?
|
| RNA, Bacterial | 1 | 2015 | 30 | 0.140 |
Why?
|
| Immunity, Humoral | 1 | 2015 | 42 | 0.130 |
Why?
|
| Immunity, Cellular | 1 | 2015 | 80 | 0.130 |
Why?
|
| Vaccination | 1 | 2016 | 182 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 626 | 0.130 |
Why?
|
| Pregnancy Complications | 1 | 2017 | 286 | 0.130 |
Why?
|
| Protein Binding | 1 | 2017 | 1027 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 370 | 0.120 |
Why?
|
| Depressive Disorder | 1 | 2017 | 621 | 0.120 |
Why?
|
| Age Factors | 1 | 2017 | 1860 | 0.100 |
Why?
|
| DNA | 2 | 2022 | 597 | 0.080 |
Why?
|
| Biomarkers | 2 | 2022 | 1593 | 0.070 |
Why?
|
| Peptidoglycan | 1 | 2022 | 14 | 0.050 |
Why?
|
| Cell Wall | 1 | 2022 | 21 | 0.050 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2022 | 118 | 0.050 |
Why?
|
| Neurofilament Proteins | 1 | 2022 | 20 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2022 | 89 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2022 | 172 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2022 | 107 | 0.050 |
Why?
|
| Hypoxia | 1 | 2022 | 169 | 0.050 |
Why?
|
| Permeability | 1 | 2021 | 131 | 0.050 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2018 | 17 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2022 | 1692 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2017 | 37 | 0.040 |
Why?
|
| Keratins | 1 | 2017 | 48 | 0.040 |
Why?
|
| Cytokines | 1 | 2022 | 866 | 0.040 |
Why?
|
| B7-1 Antigen | 1 | 2016 | 20 | 0.040 |
Why?
|
| CD40 Ligand | 1 | 2016 | 14 | 0.040 |
Why?
|
| Seasons | 1 | 2016 | 129 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2017 | 330 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2017 | 432 | 0.030 |
Why?
|
| Vaccines | 1 | 2015 | 21 | 0.030 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2014 | 8 | 0.030 |
Why?
|
| Immunoglobulin D | 1 | 2014 | 14 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1174 | 0.030 |
Why?
|
| Fas Ligand Protein | 1 | 2014 | 64 | 0.030 |
Why?
|
| fas Receptor | 1 | 2014 | 54 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2014 | 32 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 132 | 0.030 |
Why?
|
| Gene Expression | 1 | 2016 | 770 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 69 | 0.030 |
Why?
|
| Monocytes | 1 | 2014 | 210 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2014 | 201 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 901 | 0.030 |
Why?
|
| Pregnancy | 1 | 2017 | 2331 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2673 | 0.020 |
Why?
|
| Child | 1 | 2019 | 6400 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 5708 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 8903 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 2688 | 0.020 |
Why?
|
| Aged | 1 | 2017 | 14842 | 0.010 |
Why?
|